secwatch / observer
8-K filed July 14, 2025, 7:59 PM ET ticker LNAI CIK 0001527728
regulatory confidence high sentiment negative materiality 0.75

Lunai Bioworks Inc. (LNAI): Nasdaq/NYSE listing notice — Renovaro receives Nasdaq delisting notice for missing annual meeting deadline; 45 days to submit plan

Lunai Bioworks Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a), 5810(c)(2)(G)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
shareholders
Rules
5620(a), 5810(c)(2)(G)
Exact text from the filing
July 7, 2025, Renovaro Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5620(a), which requires that listed companies hold an annual meeting of shareholders no later than one year after the end of their fiscal year. The Company did not hold its annual meeting of shareholders within twelve months of the end of its fiscal year ended June 30, 2024, and therefore did not satisfy this requirement. Pursuant to Nasdaq Listi
View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR
accession 0001731122-25-000971
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.